Earum Pharmaceuticals Limited, established in 2012, operates in the pharmaceutical industry, focusing on the marketing, trading, and distribution of pharmaceutical formulation products. The company offers a diverse range of products that encompass various therapeutic categories. These include anti-biotic drugs, anti-malarial drugs, anti-allergic and anti-cold drugs, analgesic/antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium supplements, multivitamins, anti-oxidants, and injections. This extensive product portfolio enables Earum Pharmaceuticals to cater to a wide range of healthcare needs and address various medical conditions.
Earum Pharmaceuticals’ emphasis on marketing, trading, and distribution highlights its commitment to ensuring the availability and accessibility of pharmaceutical products in the market. By offering a comprehensive range of medications across different therapeutic areas, the company aims to meet the diverse needs of healthcare professionals and consumers. Through its product offerings, Earum Pharmaceuticals strives to contribute to the improvement of healthcare outcomes and enhance the well-being of individuals.
Earum Pharmaceuticals Rights Issue 2023 Detail
| Issue Open | May 2, 2023 – May 31, 2023 |
| Security Name | Earum Pharmaceuticals Limited |
| Issue Size (Shares) | 246,716,400 |
| Issue Size (Amount) | ₹49.34 Crores |
| Issue Price | ₹2 per share |
| Face Value | ₹2 per share |
| Listing At | BSE |
| Terms of Payment | Investors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call. |
| Entitlement | 4 Equity Shares for every 1 Equity Shares held on the Record Date |
Earum Pharmaceuticals Rights Issue 2023 Issue Timetable
| Last Date to buy shares | Apr 6, 2023 |
| Record Date | Apr 10, 2023 |
| Credit of Rights Entitlements | |
| Bid/Offer Opens On | May 2, 2023 |
| Renunciation of Rights Entitlements | |
| Bid/Offer Closes On | May 31, 2023 |
| Deemed Date of Allotment | |
| Credit Date | |
| Listing Date |
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Reserves and Surplus |
| 31-Mar-20 | 36.16 | 57.38 | 1.82 | 8.25 |
| 31-Mar-21 | 27.87 | 50.02 | 0.09 | 8.33 |
| 31-Mar-22 | 28.79 | 28.74 | 2.22 | 4.39 |
Objects of the Issue:
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
- For working capital requirements.
- Repayment of loan.
- General corporate purposes.
Earum Pharmaceuticals Rights Issue 2022 Documents
Company Contact Information
Earum Pharmaceuticals Limited
A-1106, Empire Business Hub,
Near AUDA Water Tank, Science City Road,
Sola, Ahmedabad – 380060
Phone: (079)-48402525
Email: cs@earumpharma.com
Website: http://www.earumpharma.com
Earum Pharmaceuticals Rights Issue 2022 Registrar
- Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: rightsissue@bigshareonline.com
Website: https://www.bigshareonline.com/
Earum Pharmaceuticals Rights Issue 2022 Lead Manager(s)
- Axis Bank Limited
